
    
      Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin
      resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm
      3 X day for 8 weeks to monitor outcomes in a pilot study.
    
  